Bosmeny Michael S, Mamede Joao I, Gagnon Keith T
Department of Biochemistry, Wake Forest University, School of Medicine, Winston-Salem, NC, USA.
Department of Microbial Pathogens and Immunity, Rush University, Chicago, IL, USA.
Epigenomics. 2025 Jun;17(8):529-540. doi: 10.1080/17501911.2025.2504333. Epub 2025 May 16.
The collection of HIV-1 RNA chemical modifications and their functional consequences in viral gene expression, host interactions, and the viral life cycle, referred to as HIV-1 epitranscriptomics, remain incompletely understood. While the field is evolving, diverse modification discovery methods, cell lines, HIV-1 sequences, and bioinformatics methods make a consensus view of the HIV-1 epitranscriptome difficult to resolve. Here, we review methods for identifying and interpreting N-methyladenosine (mA), 5-methylcytosine (mC), pseudouridine (Ψ), 2´--methylation (N), and N-acetylcytidine (acC) modifications in HIV-1, including antibody-based selection methods, chemical-treatment-based selection methods, and detection by nanopore direct RNA sequencing. We recommend the adoption of the latter as a standardized sequencing strategy to enable better benchmarking across diverse studies and help resolve HIV-1 epitranscriptomics.
对HIV-1 RNA化学修饰及其在病毒基因表达、宿主相互作用和病毒生命周期中的功能后果的研究,即HIV-1表观转录组学,目前仍未完全了解。尽管该领域在不断发展,但多样的修饰发现方法、细胞系、HIV-1序列和生物信息学方法使得对HIV-1表观转录组形成共识观点变得困难。在此,我们综述了识别和解释HIV-1中N-甲基腺苷(mA)、5-甲基胞嘧啶(mC)、假尿苷(Ψ)、2'-O-甲基化(Nm)和N-乙酰胞嘧啶(acC)修饰的方法,包括基于抗体的选择方法、基于化学处理的选择方法以及通过纳米孔直接RNA测序进行检测。我们建议采用后者作为标准化测序策略,以便在不同研究中进行更好的基准测试,并有助于解决HIV-1表观转录组学问题。